PHC presents the LiCellGrow prototype, a new cell expansion system to support the development of cell and gene therapy manufacturing processes
PHC Corporation Biomedical Division will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT Regional Meeting. LiCellGrow, currently under development, is designed to allow pharmaceutical companies to visualize continuous metabolic changes in cells in real-time and adjust the cell culture automatically to optimize conditions for cell growth. The system seeks to expand availability of cell and gene therapy (CGT) products by accelerating the manufacturing of specific cells needed for these therapies.